Published in J Gen Virol on April 01, 1993
Efficient intracellular assembly of papillomaviral vectors. J Virol (2004) 5.36
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci U S A (1995) 4.15
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virion pseudotype. J Virol (1996) 3.66
Assembly of herpes simplex virus (HSV) intermediate capsids in insect cells infected with recombinant baculoviruses expressing HSV capsid proteins. J Virol (1994) 3.24
Maturation of papillomavirus capsids. J Virol (2005) 3.18
Interaction of papillomaviruses with the cell surface. J Virol (1994) 2.44
Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Natl Acad Sci U S A (2004) 2.43
Arrangement of L2 within the papillomavirus capsid. J Virol (2008) 2.37
Generation and neutralization of pseudovirions of human papillomavirus type 33. J Virol (1997) 2.29
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains. J Virol (1998) 2.12
Enhancement of capsid gene expression: preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J Virol (2001) 2.02
Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J Virol (1998) 1.85
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Production of infectious human papillomavirus independently of viral replication and epithelial cell differentiation. Proc Natl Acad Sci U S A (2005) 1.72
Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol (2003) 1.68
Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. J Virol (1998) 1.67
Immunization with viruslike particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol (1996) 1.66
Interaction of tSNARE syntaxin 18 with the papillomavirus minor capsid protein mediates infection. J Virol (2005) 1.61
Expression of the human papillomavirus type 11 L1 capsid protein in Escherichia coli: characterization of protein domains involved in DNA binding and capsid assembly. J Virol (1997) 1.58
In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55
The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle. J Virol (2005) 1.53
Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women. Clin Diagn Lab Immunol (1997) 1.34
L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J Virol (2001) 1.34
Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol (1995) 1.32
Positively charged termini of the L2 minor capsid protein are necessary for papillomavirus infection. J Virol (2001) 1.28
Papillomavirus prophylactic vaccines: established successes, new approaches. J Virol (2009) 1.00
Bovine papillomavirus type 1 infection is mediated by SNARE syntaxin 18. J Virol (2007) 0.97
The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol J (2009) 0.93
Structure-based engineering of papillomavirus major capsid l1: controlling particle assembly. Virol J (2007) 0.92
Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1. J Virol (2002) 0.91
Detection of neutralizing antibodies against human papillomaviruses (HPV) by inhibition of gene transfer mediated by HPV pseudovirions. J Clin Microbiol (2002) 0.91
A Virus-based Vaccine May Prevent Cervical Cancer. Curr Infect Dis Rep (2005) 0.88
Self-assembly of in vitro-translated human papillomavirus type 16 L1 capsid protein into virus-like particles and antigenic reactivity of the protein. Clin Diagn Lab Immunol (1996) 0.79
Papillomavirus assembly: An overview and perspectives. Virus Res (2016) 0.75
Production of Furin-Cleaved Papillomavirus Pseudovirions and Their Use for In Vitro Neutralization Assays of L1- or L2-Specific Antibodies. Curr Protoc Microbiol (2015) 0.75
Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology (1991) 3.28
Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol (1997) 2.58
Genetic and environmental causes of variation in basal levels of blood cells. Twin Res (1999) 2.36
Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J Virol (1999) 2.35
Papillomavirus capsid binding and uptake by cells from different tissues and species. J Virol (1995) 2.24
Proline oxidase, encoded by p53-induced gene-6, catalyzes the generation of proline-dependent reactive oxygen species. Cancer Res (2001) 2.05
Association between anorectal dysplasia, human papillomavirus, and human immunodeficiency virus infection in homosexual men. Lancet (1986) 1.95
Interaction of human papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an intact L2 N-terminal sequence. J Virol (1994) 1.83
Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology (1997) 1.66
Transmission of human papillomaviruses from mother to child. Aust N Z J Obstet Gynaecol (1993) 1.63
New ubiquitin-positive intraneuronal inclusions in the extra-motor cortices in patients with amyotrophic lateral sclerosis. Neurosci Lett (1991) 1.60
Expression of the alpha6 integrin confers papillomavirus binding upon receptor-negative B-cells. Virology (1999) 1.45
DNA packaging by L1 and L2 capsid proteins of bovine papillomavirus type 1. Virology (1998) 1.33
Reactivity of anti-mitochondrial autoantibodies in primary biliary cirrhosis: definition of two novel mitochondrial polypeptide autoantigens. J Immunol (1985) 1.25
AIDS and sex education for young people in China. Reprod Fertil Dev (2001) 1.24
Identification of the nuclear localization signal of human papillomavirus type 16 L1 protein. Virology (1991) 1.21
A "public" T-helper epitope of the E7 transforming protein of human papillomavirus 16 provides cognate help for several E7 B-cell epitopes from cervical cancer-associated human papillomavirus genotypes. Proc Natl Acad Sci U S A (1991) 1.19
Presentation of the HPV16E7 protein by skin grafts is insufficient to allow graft rejection in an E7-primed animal. Virology (1997) 1.16
Blastocystis hominis infection. Lancet (1996) 1.12
HPV6b virus like particles are potent immunogens without adjuvant in man. Vaccine (2000) 1.11
Mucosal immunisation with papillomavirus virus-like particles elicits systemic and mucosal immunity in mice. Virology (1998) 1.05
The vaccinia virus K2L gene encodes a serine protease inhibitor which inhibits cell-cell fusion. Virology (1992) 1.02
Epithelial cells display separate receptors for papillomavirus VLPs and for soluble L1 capsid protein. Virology (1996) 1.01
Inhibitory monoclonal antibody against a (myristylated) small-molecular-weight antigen from Plasmodium falciparum associated with the parasitophorous vacuole membrane. Infect Immun (1988) 1.01
Identification of B epitopes in human papillomavirus type 16 E7 open reading frame protein. J Gen Virol (1990) 1.00
Incidental finding of a microsporidian parasite from an AIDS patient. J Clin Microbiol (1993) 1.00
Nucleotides 1506-1625 of bovine papillomavirus type 1 genome can enhance DNA packaging by L1/L2 capsids. Virology (1999) 1.00
BPV1 E2 protein enhances packaging of full-length plasmid DNA in BPV1 pseudovirions. Virology (2000) 1.00
Blastocystis in humans and animals: morphology, biology, and epizootiology. Adv Parasitol (1993) 1.00
A survey of the intestinal transcriptomes of the hookworms, Necator americanus and Ancylostoma caninum, using tissues isolated by laser microdissection microscopy. Int J Parasitol (2006) 0.99
Association of bovine papillomavirus type 1 with microtubules. Virology (2001) 0.98
Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res (1999) 0.98
Increase in cardiac P2X1-and P2Y2-receptor mRNA levels in congestive heart failure. Life Sci (1999) 0.96
Schistosoma japonicum: immunolocalization of paramyosin during development. Parasitology (1997) 0.95
T lymphocyte subpopulations defined by two sets of monoclonal antibodies in chronic active hepatitis and systemic lupus erythematosus. Clin Exp Immunol (1982) 0.95
Expression, purification and immunological characterization of the transforming protein E7, from cervical cancer-associated human papillomavirus type 16. Clin Exp Immunol (1999) 0.94
Global gene profiling analysis of mouse uterus during the oestrous cycle. Reproduction (2003) 0.94
Incidental finding of Myxobolus spores (protozoa: myxozoa) in stool samples from patients with gastrointestinal symptoms. J Clin Microbiol (1998) 0.93
Major population differences in T cell response to a malaria sporozoite vaccine candidate. Int Immunol (1990) 0.93
A major quantitative trait locus for CD4-CD8 ratio is located on chromosome 11. Genes Immun (2004) 0.92
Ultrastructural variation of Blastocystis hominis stocks in culture. Int J Parasitol (1989) 0.91
Antibodies to liver membrane antigens in chronic active hepatitis (CAH). II. Specificity for autoimmune CAH. Clin Exp Immunol (1983) 0.91
Detection of Blastocystis sp. in domestic dogs and cats. Vet Parasitol (1998) 0.91
Pleuroperitoneal effusion without ascites. Med J Aust (1983) 0.91
The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction. Endocrinology (2000) 0.90
Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes. J Gen Virol (1990) 0.90
Spontaneous reverse hemolytic plaque formation. III. Monocyte-mediated suppression of elevated plaque formation in autoimmune disease. Clin Immunol Immunopathol (1982) 0.89
Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine (2001) 0.89
Human papillomavirus--a study of male sexual partners. Med J Aust (1988) 0.88
Immune responses induced by BCG recombinant for human papillomavirus L1 and E7 proteins. Vaccine (2000) 0.88
Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 0.88
The parasitophorous vacuole membrane of Plasmodium falciparum: demonstration of vesicle formation using an immunoprobe. Eur J Cell Biol (1988) 0.87
Over-expression of HSP-70 protects astrocytes from combined oxygen-glucose deprivation. Neuroreport (1996) 0.87
Assessment of delayed-type hypersensitivity in man: a comparison of the "Multitest" and conventional intradermal injection of six antigens. Clin Immunol Immunopathol (1985) 0.87
Human papillomavirus type 16 E6, E7 and L1 and type 18 E7 proteins produced by recombinant baculoviruses. J Virol Methods (1993) 0.87
Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter. J Virol (2001) 0.87
Glycosylation of human papillomavirus type 16 L1 protein. Virology (1993) 0.87
Association of clinical, radiological and synovial immunopathological responses to anti-rheumatic treatment in rheumatoid arthritis. Rheumatology (Oxford) (2001) 0.86
Autoantibodies to liver antigens in chronic liver disease. I. A radioimmunoassay for antibody to liver membrane antigens. J Clin Lab Immunol (1982) 0.86
Re: Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. J Natl Cancer Inst (2001) 0.86
Congestive heart failure induces downregulation of P2X1-receptors in resistance arteries. Cardiovasc Res (1999) 0.85
Type specific and genotype cross reactive B epitopes of the L1 protein of HPV16 defined by a panel of monoclonal antibodies. Virology (1998) 0.85
Male partners of women with genital human papillomavirus infection. An assessment of colposcopic abnormalities by histological examination and human papillomavirus hybridization. Med J Aust (1989) 0.85
Identification of B-epitopes in the human papillomavirus 18 E7 open reading frame protein. J Immunol (1990) 0.85
Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes. Virology (2000) 0.85
'Acute' autoimmune hepatitis. Digestion (1986) 0.85
Th2-type CD4+ cells neither enhance nor suppress antitumor CTL activity in a mouse tumor model. J Immunol (1998) 0.84
Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines. J Gen Virol (1994) 0.84
Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen. Med J Aust (1987) 0.84
Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. Curr Top Microbiol Immunol (1994) 0.83
Hypoxic pressor response, cardiac size, and natriuretic peptides are modified by long-term intermittent hypoxia. J Appl Physiol (1985) (1999) 0.83
Reaction of vanadium(V) with thiols generates vanadium (IV) and thiyl radicals. FEBS Lett (1990) 0.83
Vaccine-induced Th1-type responses are dominant over Th2-type responses in the short term whereas pre-existing Th2 responses are dominant in the longer term. Scand J Immunol (1998) 0.83
Bile acids influence the growth, oestrogen receptor and oestrogen-regulated proteins of MCF-7 human breast cancer cells. Br J Cancer (1992) 0.83
Preparation, characterization, and anti-tumor property of podophyllotoxin-loaded solid lipid nanoparticles. Nanotechnology (2009) 0.83
Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology (1992) 0.83
The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1. Virology (1991) 0.82
Genomewide scans of red cell indices suggest linkage on chromosome 6q23. J Med Genet (2006) 0.82
An ELISA capture assay for the E7 transforming proteins of HPV16 and HPV18. J Virol Methods (1992) 0.82
Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest (1997) 0.82
Similar cardiovascular effects of growth hormone and insulin-like growth factor-I in rats after experimental myocardial infarction. Growth Horm IGF Res (2001) 0.81
Immunological abnormalities in asymptomatic homosexual men: correlation with antibody to HTLV-III and sequential changes over two years. Q J Med (1986) 0.81
The molecular specificity of linear B-epitopes in the E7 open reading frame protein of human papillomavirus 16 defined by monoclonal antibodies. Pept Res (1992) 0.81
E2F-1 induces proliferation-specific genes and suppresses squamous differentiation-specific genes in human epidermal keratinocytes. Oncogene (2000) 0.81
Differences in the post-translational modifications of human papillomavirus type 6b major capsid protein expressed from a baculovirus system compared with a vaccinia virus system. Biotechnol Appl Biochem (2000) 0.81
Topical plus subconjunctival anesthesia for phacotrabeculectomy: one year follow-up. J Cataract Refract Surg (1998) 0.81
Post translational modifications of recombinant human papillomavirus type 6b major capsid protein. Virus Res (1999) 0.81
Immunolocalisation of the glutathione S-transferases, GST-26 and GST-28, within adult Schistosoma japonicum. Int J Parasitol (1998) 0.81
Absence of autoimmune serological reactions in chronic non A, non B viral hepatitis. Clin Exp Immunol (1985) 0.80
Refractive lensectomy to correct ametropia. J Cataract Refract Surg (1999) 0.80